Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	13.28	3.09	11.25	14.55	19.99	3.02
Cash & Short-Term Investments	13.28	3.09	11.25	14.55	19.99	3.02
Cash Growth	158.00%	-72.49%	-22.69%	-27.21%	560.69%	-
Other Receivables	-	-	-	-	-	0
Receivables	-	-	-	-	-	0
Prepaid Expenses	0.53	0.41	0.42	1.03	1.67	-
Total Current Assets	13.81	3.51	11.67	15.58	21.65	3.03
Other Long-Term Assets	0.2	0.57	-	-	-	-
Total Assets	14.01	4.07	11.67	15.58	21.65	3.03
Accounts Payable	0.43	0.16	0.53	0.38	0.11	-
Accrued Expenses	0.12	0.1	0.53	0.13	0.13	0.02
Short-Term Debt	-	-	-	-	-	0.2
Total Current Liabilities	0.55	0.26	1.07	0.51	0.24	0.22
Total Liabilities	0.55	0.26	1.07	0.51	0.24	0.22
Common Stock	0.04	0.03	0.03	0.02	0.02	0.01
Additional Paid-In Capital	85.17	69.19	67.78	60.51	60.03	-
Retained Earnings	-71.74	-65.4	-57.2	-45.47	-38.64	-0.18
Total Common Equity	13.46	3.81	10.6	15.07	21.41	-0.17
Shareholders' Equity	13.46	3.81	10.6	15.07	21.41	2.8
Total Liabilities & Equity	14.01	4.07	11.67	15.58	21.65	3.03
Total Debt	-	-	-	-	-	0.2
Net Cash (Debt)	13.28	3.09	11.25	14.55	19.99	2.82
Net Cash Growth	158.00%	-72.49%	-22.69%	-27.21%	607.78%	-
Net Cash Per Share	0.44	0.12	0.45	0.62	1.47	0.24
Filing Date Shares Outstanding	41.08	25.93	25.63	23.37	23.34	12
Total Common Shares Outstanding	41.08	25.93	25.63	23.34	23.34	12
Working Capital	13.26	3.25	10.6	15.07	21.41	2.8
Book Value Per Share	0.33	0.15	0.41	0.65	0.92	-0.01
Tangible Book Value	13.46	3.81	10.6	15.07	21.41	-0.17
Tangible Book Value Per Share	0.33	0.15	0.41	0.65	0.92	-0.01

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q